METTL3 and glioblastoma: METTL3/METTL14 play a vital role in the progression of glioblastoma (21), breast (22), and liver cancer (23); FTO, notorious fat mass and obesity-associated protein, is related to the occurrence of leukemia (24), thyroid cancer (25), breast cancer, and gastric cancer (26); YTHDF2 promotes the proliferation and migration of pancreatic (27) and prostate cancer cells (25).